Evidence map›Paper›PMID 26329296›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2016

Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.

I Linares, E Molina-Portillo, J Expósito, J A Baeyens, C Suárez, M J Sánchez

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trends in lung cancer incidence in Spain (1990-2019): insights from Global Burden of Diseases data.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Does the Level of Air Pollution Affect the Incidence of Lung Adenocarcinoma in South-Eastern Poland?International journal of environmental research and public health · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Epidemiology of lung cancer in northeast of Iran: A 25-year study of 939 patients.Medical journal of the Islamic Republic of Iran · 2020
    Article
  7. Article
  8. Article
  9. A consensus statement on the gender perspective in lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Review
  10. The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

I LinaresRadiotherapy and Oncology Department, University Hospital Complex of Granada, Avda. fuerzas Armadas s/n, 18014, Granada, Spain. ilg686@hotmail.com.
E Molina-PortilloAndalusian School of Public Health, Biosanitary Investigation Institute ibs, Granada, Spain.
J ExpósitoRadiotherapy and Oncology Department, University Hospital Complex of Granada, Avda. fuerzas Armadas s/n, 18014, Granada, Spain.
J A BaeyensLa Chana Health Centre, Granada Health District, Granada, Spain.
C SuárezPhysical Therapy Department, University of Seville, Calle Avenzoar, 6, 41009, Seville, Spain.
M J SánchezAndalusian School of Public Health, Biosanitary Investigation Institute ibs, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyze and interpret age- and sex-specific incidence trends of lung cancer in Granada over the period 1985-2012 and to further analyze these trends by histologic subtype.

methodsIncidence data were obtained from the population-based cancer registry located in Granada (Southern Spain). All cases with newly diagnosed primary lung cancer over the period 1985-2012 (n = 8658) and defined by International Classification of Diseases 10th Revision (codes C33-C34) were included. Joinpoint regression analysis of age-standardized incidence rates was used to estimate the annual percent change (APC) and 95% confidence intervals. Results are presented overall and by sex, age groups (0-34, 35-54, 55-64, 65-74, ≥75 years) and histologic subtypes.

resultsTemporal trends of incidence rates by sex, over the period 1985-2012, showed a distinct pattern. A significant change point of the trend was observed in males in 1994 (APC: +2.5%; 95% CI 0.7-4.4 from 1985 to 1994 and -1.4%; 95% CI -2.0 to -0.7 from 1994 onward). This general change was mainly caused by the age group 65-74 years and by the higher incidence of squamous cell carcinoma histologic subtype. In females, lung cancer incidence increased over the entire study period by +4.2% per year (95% CI 3.1-5.4); this trend was mainly caused by the age group 55-64 years (APC = +7%) and by adenocarcinoma incidence between women (APC = +6.8%).

conclusionMale lung cancer incidence rates have decreased in Granada, while female rates have increased overall especially in younger women. These trends may reflect the increased consumption of cigarettes in women, especially during younger ages. Lung cancer prevention through tobacco control policies are therefore of utmost importance.

Indexed as

AdenocarcinomaAdolescentAdultAgedCarcinoma, Large CellCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellChildChild, PreschoolFemaleFollow-Up StudiesHumansIncidenceInfantInfant, NewbornLung NeoplasmsHistologic typesIncidenceLung cancerPopulation-based studySex differencesTrends

Identifiers

PMID26329296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.